CNBC Pro

Moderna, Nio, Carrier: CNBC’s Halftime Report traders answer your questions on these stocks

Share
A medical worker from Parrish Medical Center holds a vial of the Moderna COVID-19 vaccine at a drive through vaccination clinic for employees of Port Canaveral, workers at local hotels and restaurants, and residents of the Port Canaveral community.
Paul Hennessy | LightRocket | Getty Images

CNBC's "Halftime Report" traders answered questions from CNBC Pro subscribers, including how to approach investing in Moderna, whether to buy U.S.-listed Chinese stocks like Nio, and if home appliances company Carrier Global is a name to hold in the long term.

More In CNBC TV Picks

CNBC ProCramer thinks investors should buy this fintech stock on the dip
CNBC ProCramer says Robinhood's IPO 'plays with fire' and is the 'toughest one I've ever seen'
CNBC ProCramer says 'Elon Musk ended the magic,' making Tesla sound like a regular car company